Diabetes

Semaglutide GLP-1 Receptor Agonists Type 2 Diabetes Tirzepatide Metformin GLP-1 Agonists GLP-1 Medications

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

Researchers are moving from positive type 1 diabetes trial results into planned randomized studies to test semaglutide’s potential to prevent dementia.

8 ARTICLES

last mo.

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging

Diabetes

Semaglutide Demonstrates Dual Promise in Type 1 Diabetes and Dementia Prevention

GLP-1 Drugs Linked to Lower Cancer Risk and Mortality in New Study

FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes Patients

Ozempic May Lower Alzheimer's Risk in Type 2 Diabetics, Study Finds

Diabetes Drug Metformin Shows Promise in Slowing Brain Aging